About Us
Focus
History
Structure
Investors
Portfolio
All
Agritech
Cleantech
Information Technology
Material Science
Medical Devices
Pharma - Biotech
Security
News
News
Newsletters
Team
Management
Senior Advisors
Board
For Entrepreneurs
For Investors
Contact Us
Home
Search
News > All
--- Select---
The Trendlines Group
Misgav Venture Accelerator
Mofet Innovation Accelerator
Signal Business Development
Portfolio Companies
All
News about the Misgav Venture Accelerator
7/1/2010
Todd Dollinger gives his impressions about this years' Medica.
1/1/2009
PolyTouch Medical Ltd. Announces Chairman of the Board
1/7/2010
Misgav Newsletter Q2 2010
1/1/2009
ETView inks a deal with CODAN AB
1/4/2010
Misgav Newsletter Q 1 2010
7/1/2010
Wound care co EnzySurge raises $4.1m
7/1/2010
Misgav Newsletter Q4 2009
22/12/2009
EnzySurge Secures US$2.5 Million in Private Capital
15/12/2009
Wound treatment co EnzySurge gets FDA nod
5/1/2009
The Misgav Venture Accelerator Sums Up Another Successful Year
15/12/2009
Successful entrepreneur helps develop R&D for HTL and Life Bond - (Heb)
19/10/2009
Misgav newsletter Q3 2009
25/10/2009
A new treatment for chronic wounds
7/7/2009
Misgav newsletter Q2 2009
11/10/2009
HTL signs with Cheisi Group (Hebrew)
24/6/2009
Misgav Venture Accelerator at Biomed Israel 2009 -- photo gallery
7/10/2009
HTL signs agreemeent with leading Italian pharmaceutical company
21/6/2009
The incubator that put down roots in the Galilee (Hebrew)
24/9/2009
Infection Control Today article mentions Flexicath
4/2/2009
DailyMaily interview with Steve Rhodes (Hebrew)
29/9/2009
OMNIVISION PROVIDES DISPOSABLE CAMERAS FOR NEXT GENERATION MEDICAL INTUBATION SYSTEM
24/3/2009
Misgav Newsletter Q1 2009
29/9/2009
Good news from the FDA for Flexicath
14/9/2009
Virtual Ports raises $2.6 million (Hebrew)
16/9/2009
Gluing together expertise to help save lives
15/9/2009
Laparoscopy co Virtual Ports raises $2.6m
29/12/2008
Misgav Newsletter Q4 2008
15/9/2009
Scorpion Surgical Technologies appears in Biomedical Business & Technology
22/10/2008
Misgav Newsletter Q3 2008
8/9/2009
Immunovative Therapies to raise $2m for human trials
13/7/2008
Misgav Newsletter Q2 2008
8/9/2009
Immunovative seeks $2 million (Hebrew)
13/4/2008
Misgav Newsletter Q1 2008
16/8/2009
Catheter co Flexicath signs $1m US cooperation deal
17/8/2009
Virtual Ports receives CE approval for laparoscopic tools (Hebrew)
25/12/2007
Misgav Newsletter Q4 2007
16/8/2009
CryoStim cancer treatment to begin FDA clinical trials September 1, 2009
16/7/2009
Israeli company designing innovative spine implants
30/6/2009
ID-U completes performance evaluation
1/10/2007
Misgav Newsletter Q3 2007
23/6/2009
ETView signs distribution agreement (Hebrew)
23/6/2009
ETView signs US distribution deal
20/5/2009
Stimatix recieves Ministry of Industry, Trade & Labor approval (Hebrew)
16/6/2009
PolyTouch takes second place in Most Promising Life Science Initiative (Hebrew)
9/6/2009
Virtual Ports one of the "most promising" biomed start-ups (Hebrew)
2/6/2009
LifeBond completes $8 million funding round
1/4/2007
Misgav Newsletter Q2 2007
5/1/2007
Misgav Newsletter Q1 2007
7/5/2009
Virtual Ports begins official market launch
1/3/2009
Scorpion reports successful pre-clinical trial (Hebrew)
4/12/2008
Medical device co Flexicath raises $600,000
1/1/2006
JetGuide
1/1/2006
Lavi Cardiatec
News about The Trendlines Group
19/7/2009
Misgav Named 2010 Incubator of the Year
20/12/2008
In defense of finders
15/8/2008
5 challenges about raising money
20/10/2008
Raising money – again: 7 thoughts for cycle survival
15/4/2008
Todd's 7 dirty words
15/10/2003
Business Development for Life Sciences Companies: It’s Only Natural
27/10/2004
$400,000 fund set to help homeland security firms
3/6/2005
MIDC Introduction Leads to Investment in Israeli Venture Fund
25/5/2005
Maryland-Israel Development Fund Launched
Home
|
Directions
|
Privacy Policy
|
Site Map
|
Tel
: +972.72.260.7000
2009 - 2010 The Trendlines Group Ltd. All rights reserved